CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Organovo Holdings, Inc.  (ONVO)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
 
 

ONVO's Revenue Year on Year Growth by Quarter and Year

Organovo Holdings,'s Revenue results by quarter and year



Select the Comparisons : Select the Ratio:                        
ONVO Revenue (in millions $) FY 2017 FY 2016 FY 2015 FY 2014
IV Quarter March - 0.55 0.27 0.12
III Quarter December 1.15 0.33 0.16 0.14
II Quarter September 1.38 0.30 0.05 0.02
I Quarter June 0.89 0.31 0.10 0.11
FY   3.42 1.49 0.58 0.39

Financial Statements
Organovo Holdings,'s third quarter 2017 Revenue $ 1.15 millions ONVO's Income Statement
Organovo Holdings,'s third quarter 2016 Revenue $ 0.33 millions Quarterly ONVO's Income Statement
ONVO's Growth by Division See ONVO's Growth by Segment

ONVO Revenue ( Y/Y Growth %) 2017
2016 2015 2014
IV Quarter March - 103.7 % 125 % -65.71 %
III Quarter December 248.79 % 106.25 % 14.29 % -70.21 %
II Quarter September 360 % 500 % 150 % -92.31 %
I Quarter June 187.1 % 210 % -9.09 % -8.33 %
FY   - 156.9 % 48.72 % -



ONVO Revenue Growth Comment
Organovo Holdings, Inc. achieved in the third quarter, above Company average Revenue surge of 248.79% year on year, to $ 1.15 millions.

Looking into third quarter results within Biotechnology & Drugs industry 9 other companies have achieved higher Revenue growth. While Organovo Holdings, Inc.' s Revenue doubling of 248.79% ranks overall at the positon no. 126 in the third quarter.



Revenue Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #10
Healthcare Sector #32
S&P 500 #126
Revenue Y/Y Growth Statistics
High Average Low
502 % 126.39 % -95.1 %
(Sep 30 2015)   (Sep 30 2013)

You need to upgrade your Flash Player

Other Revenue Growth
Biotechnology & Drugs Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
ONVO's Revenue Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for ONVO's Competitors
Revenue Growth for Organovo Holdings,'s Suppliers
Revenue Growth for ONVO's Customers

You may also want to know
ONVO's Annual Growth Rates ONVO's Profitability Ratios ONVO's Asset Turnover Ratio ONVO's Dividend Growth
ONVO's Roe ONVO's Valuation Ratios ONVO's Financial Strength Ratios ONVO's Dividend Payout Ratio
ONVO's Roa ONVO's Inventory Turnover Ratio ONVO's Growth Rates ONVO's Dividend Comparisons



Companies with similar Revenue doubling for the quarter ending Dec 31 2016 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2016
Juno Therapeutics, Inc.  409.47 %$ 409.465 millions
Gtx Corp  374.22 %$ 374.216 millions
China Senior Living Industry International Holding  358.34 %$ 358.342 millions
Eagle Pharmaceuticals, Inc.  346.31 %$ 346.315 millions
Nuo Therapeutics, Inc.  336.84 %$ 336.844 millions
Sarepta Therapeutics, Inc.  332.64 %$ 332.642 millions
Positiveid Corp  280.62 %$ 280.620 millions
Acelrx Pharmaceuticals Inc  271.97 %$ 271.965 millions
Agios Pharmaceuticals Inc  264.23 %$ 264.233 millions
Aradigm Corp  257.14 %$ 257.143 millions
Organovo Holdings, Inc.  250.91 %$ 250.915 millions
Cord Blood America, Inc.  250.14 %$ 250.144 millions
Neuralstem, Inc.  249.84 %$ 249.840 millions
Cytokinetics Inc  239.62 %$ 239.623 millions
Viveve Medical, Inc.  226.06 %$ 226.064 millions
Intra-cellular Therapies, Inc.  219.30 %$ 219.303 millions
Ionis Pharmaceuticals Inc  210.93 %$ 210.929 millions
Portola Pharmaceuticals Inc  210.22 %$ 210.217 millions
Sorrento Therapeutics, Inc.  200.60 %$ 200.598 millions
Catasys, Inc.  200.16 %$ 200.158 millions
Invitae Corp  192.19 %$ 192.186 millions
Asterias Biotherapeutics, Inc.  188.19 %$ 188.186 millions
Merrimack Pharmaceuticals Inc  185.93 %$ 185.928 millions
Orexigen Therapeutics, Inc.  181.49 %$ 181.488 millions
Dariohealth Corp.  172.08 %$ 172.078 millions
Medite Cancer Diagnostics, Inc.  153.28 %$ 153.279 millions
Juniper Pharmaceuticals Inc  152.38 %$ 152.382 millions
Enumeral Biomedical Holdings, Inc.  137.96 %$ 137.955 millions
Flex Pharma, Inc.  133.19 %$ 133.193 millions
Alnylam Pharmaceuticals, Inc.  131.15 %$ 131.148 millions
Economy

Advance Monthly Sales
Consumer Price Index CPI
Producer Price Index PPI
Retail Inventories
Personal Income
Gross Domestic Product GDP
Money Supply
Industrial Production
Productivity
Employment Situation
US International Trade
Factory Orders
Durable Goods
Construction Spending
Housing Starts
Vehicle Unit Sales
Stocks

Event Calendar
KDUS's Profile
Stock Price
KDUS's Financials
KDUS's Expectations
Business Description
Fundamentals
Charts & Quotes
KDUS's News
Suppliers
KDUS's Competitors
Customers & Markets
Economic Indicators
KDUS's Growth
Company Segments
Industries

At a Glance
Performance
Growth Rates
Profitability
Valuation
Financial Strength
Markets

At a Glance
Stocks
Indices
Sectors & Industries
Financials
Commodities
Currencies
Screening

Stock Performance
Growth Rates
Profitability
Valuation
Dividend
Financial Strength
Efficiency
Expectations
Management Effectivness
News

At a Glance
Stocks
Economy
Industries
Other
Glossary

Financial Terms
Technical Analysis
Fundamental Analysis
Energy Terms
Manufacturing Terms
Transportation Terms
Health Care
Insurance Terms
Economy Terms
Hotel & Leisure Terms
Help

Sitemap
Advertise
About us
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com